These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1980278)

  • 1. Multicenter evaluation of the hemodynamic effects of bisoprolol in patients with mild to moderate hypertension.
    Prisant LM; Carr AA; Desnoyers M; Westcott RJ; Zinny MA; O'Donnell DM; Bryzinski B; McKee B; Nelson BR
    J Clin Pharmacol; 1990 Dec; 30(12):1096-101. PubMed ID: 1980278
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A randomized double-blind study of bisoprolol versus atenolol in mild to moderate essential hypertension.
    Dixon MS; Thomas P; Sheridan DJ
    Eur J Clin Pharmacol; 1990; 38(1):21-4. PubMed ID: 1970298
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of bisoprolol and atenolol in the treatment of mild to moderate hypertension.
    Lewis R; Maclean D; Ioannides C; Johnston A; McDevitt DG
    Br J Clin Pharmacol; 1988 Jul; 26(1):53-9. PubMed ID: 2904825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of different bisoprolol doses on hemodynamics, plasma catecholamines, platelet aggregation, and alpha 2- and beta-receptors in hypertensive patients.
    Kirsten R; Neff J; Heintz B; Nemeth N; Rahlfs VW; Nelson K
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S113-21. PubMed ID: 2439781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bisoprolol, a once-a-day beta-blocking agent for patients with mild to moderate hypertension.
    Davidov ME; Singh SP; Vlachakis ND; Blumenthal JB; Simon JS; Bryzinski BS; Koury KJ; Alemayehu D
    Clin Cardiol; 1994 May; 17(5):263-8. PubMed ID: 8004841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS).
    Bühler FR; Berglund G; Anderson OK; Brunner HR; Scherrer U; van Brummelen P; Distler A; Philipp T; Fogari R; Mimran A
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S122-7. PubMed ID: 2439782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical evaluation of bisoprolol in patients with hypertension: interim report.
    Ikeda M; Inagaki Y; Iimura O; Kuramoto K; Takeda T
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S139-42. PubMed ID: 2439785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
    Chatterjee SS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S74-7. PubMed ID: 2439803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Casual versus ambulatory twenty-four-hour blood pressure measurement in a comparative study with bisoprolol or nitrendipine.
    Mengden T; Schubert M; Jeck T; Edmonds D; Vetter W
    J Hypertens Suppl; 1990 Sep; 8(4):S91-4. PubMed ID: 1979615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of bisoprolol fumarate on left ventricular size, function, and exercise capacity in patients with heart failure: analysis with magnetic resonance myocardial tagging.
    Dubach P; Myers J; Bonetti P; Schertler T; Froelicher V; Wagner D; Scheidegger M; Stuber M; Luchinger R; Schwitter J; Hess O
    Am Heart J; 2002 Apr; 143(4):676-83. PubMed ID: 11923805
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age dependence of therapy result and risk in the treatment of arterial hypertension?
    Höffler D; Morgenstern HO
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bisoprolol and nifedipine SR in the treatment of hypertension in the elderly.
    Oliván Martinez J; Garcia MJ; Rodriguez Botaro A; Pizarro JL; Carretero J; Garrido M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S95-9. PubMed ID: 11527144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of bisoprolol and atenolol in patients with mild to moderate hypertension: a double-blind, parallel group international multicentre study.
    Lithell H; Selinus I; Hosie J; Frithz G; Weiner L
    Eur Heart J; 1987 Dec; 8 Suppl M():55-64. PubMed ID: 2967186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Noninvasive assessment of left ventricular performance after administration of bisoprolol.
    Esper RJ; Esper RC; Burrieza OH; Menna J
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S87-91. PubMed ID: 2439806
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sildenafil citrate and blood-pressure-lowering drugs: results of drug interaction studies with an organic nitrate and a calcium antagonist.
    Webb DJ; Freestone S; Allen MJ; Muirhead GJ
    Am J Cardiol; 1999 Mar; 83(5A):21C-28C. PubMed ID: 10078539
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of bisoprolol on blood pressure and arterial hemodynamics in systemic hypertension.
    Asmar RG; Kerihuel JC; Girerd XJ; Safar ME
    Am J Cardiol; 1991 Jul; 68(1):61-4. PubMed ID: 1676238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of ambulatory blood pressure monitoring in differentiating between antihypertensive agents.
    Neutel JM; Smith DH; Ram CV; Kaplan NM; Papademetriou V; Fagan TC; Lefkowitz MP; Kazempour MK; Weber MA
    Am J Med; 1993 Feb; 94(2):181-7. PubMed ID: 8430713
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic comparison of controlled-release carvedilol and immediate-release carvedilol at steady state in patients with hypertension.
    Henderson LS; Tenero DM; Baidoo CA; Campanile AM; Harter AH; Boyle D; Danoff TM
    Am J Cardiol; 2006 Oct; 98(7A):17L-26L. PubMed ID: 17023228
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing beta-blocking effects of bisoprolol, carvedilol and nebivolol.
    Stoschitzky K; Stoschitzky G; Brussee H; Bonelli C; Dobnig H
    Cardiology; 2006; 106(4):199-206. PubMed ID: 16679760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and tolerability of nebivolol monotherapy by baseline systolic blood pressure: a retrospective analysis of pooled data from two multicenter, 12-week, randomized, double-blind, placebo-controlled, parallel-group, dose-ranging studies in patients with mild to moderate essential hypertension.
    Germino FW
    Clin Ther; 2009 Sep; 31(9):1946-56. PubMed ID: 19843484
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.